- Home
- CETX vs DRMA Comparison
CETX vs DRMA Comparison
Compare CETX & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CETX
- DRMA
- Stock Information
- Founded
- CETX 1998
- DRMA 2014
- Country
- CETX United States
- DRMA United States
- Employees
- CETX N/A
- DRMA N/A
- Industry
- CETX EDP Services
- DRMA Biotechnology: Pharmaceutical Preparations
- Sector
- CETX Technology
- DRMA Health Care
- Exchange
- CETX Nasdaq
- DRMA Nasdaq
- Market Cap
- CETX 2.3M
- DRMA 2.2M
- IPO Year
- CETX 1998
- DRMA 2021
- Fundamental
- Price
- CETX $3.00
- DRMA $1.06
- Analyst Decision
- CETX
- DRMA Strong Buy
- Analyst Count
- CETX 0
- DRMA 1
- Target Price
- CETX N/A
- DRMA $6.00
- AVG Volume (30 Days)
- CETX 912.3K
- DRMA 588.9K
- Earning Date
- CETX 02-10-2025
- DRMA 11-13-2024
- Dividend Yield
- CETX N/A
- DRMA N/A
- EPS Growth
- CETX N/A
- DRMA N/A
- EPS
- CETX N/A
- DRMA N/A
- Revenue
- CETX $65,318,942.00
- DRMA N/A
- Revenue This Year
- CETX $17.30
- DRMA N/A
- Revenue Next Year
- CETX $15.00
- DRMA N/A
- P/E Ratio
- CETX N/A
- DRMA N/A
- Revenue Growth
- CETX 19.78
- DRMA N/A
- 52 Week Low
- CETX $2.71
- DRMA $1.03
- 52 Week High
- CETX $13,629.00
- DRMA $13.35
- Technical
- Relative Strength Index (RSI)
- CETX 18.18
- DRMA 41.39
- Support Level
- CETX $3.10
- DRMA $1.03
- Resistance Level
- CETX $3.54
- DRMA $1.43
- Average True Range (ATR)
- CETX 0.35
- DRMA 0.14
- MACD
- CETX 2.30
- DRMA -0.01
- Stochastic Oscillator
- CETX 28.08
- DRMA 11.90
About CETX Cemtrex Inc.
Cemtrex Inc is a multi-industry technology company. It has expanded in a range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security system. The company's operating segment includes the Security segment, Industrial Services segment and the Corporate segment. It generates maximum revenue from the Security segment. It geographically operates in USA, UK and India wherein maximum revenue is generated in USA.
About DRMA Dermata Therapeutics Inc.
Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.